RB1 and neoplasm: In this scenario, the increased tumor suppressor capacity of RB mediated by the phosphorylation of Ser249/T252 opens up the possibility of developing a new generation of cancer drugs that mimic the effects observed by these phosphorylation events, thereby increasing the repressor capacity of RB.